The filing shows accelerating cash burn and a deteriorating balance sheet with negative equity. Traders should watch for a potential going-concern warning, equity dilution via the convertible promissory notes ($1.6M), or a reverse stock split to maintain Nasdaq listing. No guidance was provided, increasing uncertainty.
Price Chart
Executive Summary
IM Cannabis Corp. reported Q2 2026 revenue of $7.6M (down 40% YoY from $12.7M) and a net loss of $4.4M ($0.47/share), widening from a $0.2M loss in Q2 2025. The company's cash position fell to $1.6M against $30.3M in total liabilities, with a shareholders' deficit of $5.5M, indicating ongoing financial distress. No guidance or consensus estimates were provided, making the surprise calculation impossible, but the sharp revenue decline and deepening losses are clearly bearish.
Key Financial Metrics
Key Facts
- Q2 2026 revenue of $7.6M, down 40.2% from $12.7M in Q2 2025.
- Q2 2026 net loss of $4.4M ($0.47/share), compared to a net loss of $0.2M ($0.09/share) in Q2 2025.
- Operating loss widened to $2.1M in Q2 2026 from $0.4M in Q2 2025.
- Cash and restricted cash totaled $1.7M as of June 30, 2026, down from $3.3M at Dec 31, 2025.
- Total liabilities of $30.3M exceed total assets of $24.7M, resulting in a shareholders' deficit of $5.5M.
- Gross profit margin compressed to 19.8% in Q2 2026 from 27.0% in Q2 2025.
Financial Impact
Revenue decline of $5.1M YoY (40%) and net loss increase of $4.2M YoY in Q2 2026; cash burn of ~$1.6M over six months.
Risk Factors
- Going-concern risk: negative shareholders' equity of $5.5M and cash of only $1.6M against $30.3M in liabilities.
- Dilution risk: $1.6M in convertible promissory notes and derivative warrant liabilities outstanding.
- Nasdaq delisting risk: market cap of $1M and sustained losses may trigger non-compliance.
- Revenue decline of 40% YoY signals loss of market share or operational issues in Israel/Germany.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302851407 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | EFFECT | $1.19 $0.9250 | ▼ −22.27% | ▼ −21.09% | $0.8780 (−26.22%) |
Oct 2, 2026 23d ago | 6-K | $1.94 $1.94 | · 0.00% | ▼ −0.55% | $0.8780 (−54.74%) |
Sep 25, 2026 4w ago | 6-K | $2.48 $2.45 | ▲ +1.21% | ▲ +1.03% | $0.8780 (+64.60%) |
Sep 24, 2026 4w ago | 424B5 | $3.18 $2.84 | ▲ +10.69% | ▲ +11.24% | $0.8780 (+72.39%) |
Sep 24, 2026 4w ago | 6-K | $3.18 $2.84 | ▲ +10.69% | ▲ +11.24% | $0.8780 (+72.39%) |
Sep 23, 2026 4w ago | 6-K | $2.91 $3.18 | ▲ +9.28% | ▲ +9.36% | $0.8780 (−69.83%) |
Aug 17, 2026 9w ago | 6-K | $0.1050 | awaiting T+1 | — | $0.8780 (+736.19%) |
Aug 13, 2026 10w ago | Press Release | $3.66 $3.15 | ▲ +13.93% | ▲ +13.46% | $0.8780 (+76.01%) |
Aug 13, 2026 10w ago | 6-K | $3.66 $3.15 | ▲ +13.93% | ▲ +13.46% | $0.8780 (+76.01%) |
Jul 27, 2026 12w ago | 6-K | $0.1088 | awaiting T+1 | — | $0.8780 (+706.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers